Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
03/1999
03/23/1999US5886179 Nucleotide analogs
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents
03/23/1999US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors
03/23/1999US5886022 Treatment of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis bullosa
03/23/1999US5886017 Protein kinase C modulators. E.
03/23/1999CA2154263C Process for the preparation of lithium diarylphosphides and alkylated derivatives thereof
03/23/1999CA2143353C Magnetic recording binder containing aminoalkylphosphonate salt
03/23/1999CA2031505C Phospholipid derivative
03/18/1999WO1999012942A1 Method for preparing oxazaphosphorin-2-amines
03/18/1999WO1999012938A1 Weakly coordinating anions containing polyfluoroalkoxide ligands
03/18/1999WO1999012929A2 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
03/18/1999WO1999012875A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999DE19834152A1 Separating trivalent actinide elements from lanthanides
03/18/1999DE19740180A1 Nickel (0) phosphonite complex useful in production of organic nitriles
03/18/1999CA2303444A1 Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
03/18/1999CA2302559A1 Weakly coordinating anions containing polyfluoroalkoxide ligands
03/17/1999EP0902033A1 Spiro compound and photochromic material
03/17/1999EP0902032A1 Improved process for the preparation of phosphites
03/17/1999EP0901996A1 Process for producing optically active amines
03/17/1999EP0901811A2 Mixtures of long chain alkyl esters of orthophosphoric acids
03/17/1999EP0901500A1 $i(IN SITU) PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE IN SYNTHESIS OF OLIGONUCLEOTIDES
03/17/1999EP0678087B1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
03/17/1999CN1042537C Process for preparation of azamacrocyclic or acylic aminophosphonate ester derivatives
03/17/1999CA2246221A1 3-(1,2-benzisothiazol- and isoxazol-5-yl)-2,4(1h,3h)-pyrimidinedione or thione and 3-(1,2-benzisothiazol- and isoxazol-5-yl)-4(3h)-pyrimidinone or thione herbicidal agents
03/16/1999US5883297 Forming the triamides from phosphoryl dichlorides and ammonia
03/16/1999US5883296 Alkali metal hydroxide, alkane halide and tris/hydrocarbylamino/phosphoroamidite hydrohalide
03/16/1999US5883280 Process for the preparation of phosphoric monoester
03/16/1999US5883277 Olefin polymerization catalysts; complexing, quaternization
03/16/1999US5883247 Acylation with aminothiazole derivative activated as mixed anhydride of thiophosphoric acid
03/16/1999US5883237 Oligonucleotides having Rp and Sp linkages at predetermined locations
03/16/1999US5883165 Stabilizer combination for the rotomolding process
03/16/1999US5883122 Neuroprotective agents
03/11/1999WO1999011644A1 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011624A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999WO1999011623A1 Thioalkyl compounds, methods, and compositions for inhibiting parp activity
03/11/1999WO1999011622A1 Amino-substituted compounds, methods, and compositions for inhibiting parp activity
03/11/1999DE19740403A1 New tri:iodo-phenyl compounds used in diagnosis and therapy
03/11/1999DE19738822A1 Transition metal oxoporphine derivatives useful e.g. as pigment, photosensitizer or catalyst
03/11/1999CA2294118A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/10/1999EP0900805A2 Incorporation of selectably cleavable and/or abasic sites into oligonucleotide chains and reagents therefor
03/10/1999EP0900230A2 Esculetin derivatives
03/10/1999EP0900227A1 Improved process for the synthesis of diesters of phosphoric acid 2,5-dioxo-4,4-diphenyl-imidazolidin-1-ylmethyl ester
03/10/1999EP0900226A1 P or as derivative of a cyclopentadiene
03/10/1999EP0900195A1 Cyclopentadiene compound substituted with branched alkyl groups
03/10/1999EP0900187A1 Processes for producing hydroxyaldehydes
03/10/1999EP0900075A1 Radiation-protective phospholipid
03/10/1999EP0900015A1 Fungicide salts
03/10/1999CN1210560A Method for making lysophosphatidylcholine
03/10/1999CN1210540A Triazole derivatives useful in therapy
03/10/1999CN1210538A Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/10/1999CN1210513A Method of preparing aldehydes by hydroformylation with rhodium catalyst and recovery of the rhodium catalyst by extraction
03/10/1999CN1042427C Synthesis of 2-hydroxy-2-phosphono-acetic acid
03/10/1999CN1042426C Synthesis of O,S-dialkyl-dithiophosphoryl chloride
03/10/1999CN1042425C 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
03/10/1999CN1042400C 羰基化催化剂 Carbonylation catalyst
03/09/1999US5880729 Graphical user interfaces having animated control elements
03/09/1999US5880309 Dialkyl dialkoxycarbonylphenyl phosphonates useful as resin modifiers produced at high yield and low cost by heating a trialkyl phosphite and a dialkoxycarbonylphenyl halide in the presence of a palladium or nickel catalyst and hydrolyzing
03/09/1999US5880308 Process for preparing aromatic bisphosphates
03/09/1999US5880295 Process for the preparation of diamine intermediates useful in the synthesis of HIV protease inhibitors
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/09/1999US5880112 Naaladase inhibitors
03/09/1999US5880111 Therapeutic derivations of diphosphonates
03/09/1999US5880099 Inositol polyphosphates and methods of using same
03/09/1999US5879930 Process for the enzymatic resolution of 2-amino-4-methyl-phosphinobutyric acid derivatives
03/09/1999US5879700 Treating herpes virus infections
03/09/1999US5879445 Thinners for aqueous suspensions of mineral particles and hydraulic binder pastes
03/04/1999WO1999010545A1 Method for separating actinides and lanthanides by liquid-liquid extraction using calixarenes
03/04/1999WO1999010362A1 Branched dendrimeric structures
03/04/1999WO1999010356A1 Method for producing ruthenium complexes
03/04/1999WO1999010355A1 Method for producing phosphonic acid derivatives
03/04/1999WO1999010354A1 Phosphoric ester compounds and process for producing the same, copper phosphoric ester compounds and process for producing the same, near infrared absorber, and near infrared absorbent acrylic resin composition
03/04/1999WO1999010332A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999WO1999010087A1 Method for separating actinides and lanthanides by membrane transport using a calixarene
03/04/1999WO1999009963A2 Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression
03/04/1999WO1998043678A3 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
03/04/1999DE19738084A1 New 3-aryl-methyl-uracil derivatives
03/04/1999DE19738005A1 Use of known and new bis:phosphonate compounds
03/04/1999DE19737460A1 Preparation of 1,1-di:alkoxy alkyl phosphorous ester(s)
03/04/1999CA2301713A1 Method for producing ruthenium complexes
03/04/1999CA2294548A1 Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/03/1999EP0898574A1 Fluorescent chelates as visual tissue specific imaging agents
03/03/1999EP0898573A1 Aryl diphosphines and catalysts containing the same
03/03/1999EP0898557A1 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
03/03/1999CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor
03/03/1999CN1209433A Dimercapto methyl propionate-di-(isootyl thioglycolate)-dodec-sulfenyl-antimony compound, preparation method and use thereof
03/03/1999CN1042337C Process for preparing addition salt of N-phosphonomethylglycinonitrile alkylate
03/03/1999CN1042329C Substituted cyclohexane derivative for curing diseases
03/02/1999USRE36128 Stabilizer for organic compounds
03/02/1999US5877333 1,2-dioxetane derivatives
03/02/1999US5877328 Process for synthesizing carbapenem side chain intermediates
03/02/1999US5877312 Method for preparing alkylating agents for their use for alkylating cyclic ureas
03/02/1999US5877219 Non-steroidal ligands for the estrogen receptor
03/02/1999US5877210 Controlling immune response
03/02/1999US5877196 N- 4-(imidazolyl or pyrazolyl)phenyl(oxy, sulfinyl, sulfenyl or sulfonyl)alkyl!carboxamides, sulfonamides or phosphoramides having antiarrhythmic properties
03/02/1999US5877167 Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives
03/02/1999US5877166 Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
03/02/1999US5876693 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 554